A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
Clinical trial NCT06993792 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06993792
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-15
- Primary completion
- 2027-08-01
- Enrollment
- 1400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.